Paul E. Freiman - May 11, 2023 Form 4 Insider Report for NovaBay Pharmaceuticals, Inc. (NBY)

Role
Director
Signature
/s/ Justin Hall as attorney in fact for Paul E. Freiman
Stock symbol
NBY
Transactions as of
May 11, 2023
Transactions value $
$0
Form type
4
Date filed
5/15/2023, 06:54 PM
Previous filing
May 24, 2022
Next filing
Jun 13, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NBY Common Stock Options Exercise +858 +100% 1.72K May 11, 2023 Direct F1, F2
holding NBY Common Stock 67 May 11, 2023 By trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NBY Restricted Stock Units Options Exercise $0 -858 -100% $0.00* 0 May 11, 2023 Common Stock 858 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On November 15, 2022, NovaBay Pharmaceuticals, Inc. effected a 1-for-35 reverse stock split of its common stock, which is reflected in the number of shares.
F2 Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vested on the one year anniversary of the date of grant.